NEWARK, Del, Nov. 14, 2022 (GLOBE NEWSWIRE) -- The global 3D cell culture market is anticipated to account for a growth rate of around 9.8% over the forecast period from 2022 to 2031. The global market is expected to account for around US$ 1.15 Bn in 2022 and attain a valuation of US$ 2.67 Bn by 2031. According to the analysis done by Future Market Insights, the global 3D cell culture market accounted for a CAGR of 4.8% in 2021. During the historical period of 2016 to 2021, the 3D cell culture market expanded at a CAGR of 7.1%. According to the studies conducted by Future Market Insights, the comparative analysis along with the market growth rate of the global 3D cell culture market is expected to show a negative BPS growth in the H1-2022 outlook as compared to H1-2022 projected period by 10 BPS, However, a positive BPS growth is expected in H1-2022 over H1- 2021 duration with 02 Basis Point Share (BPS).
The global 3D cell culture market observes a drop in the BPS values owned to its disadvantage as compared to surface 2D cultures throughout the mass transfer process, thus making it a time-consuming and cost-incurring factor for manufacturers. Conversely, there is present, a phenomenal surge in the BPS value by 02 points indicating a positive market outlook. The rise in the BPS values is associated with the adoption of innovative cell culture devices for more predictive 3D models, thus promoting cost reduction, and limiting production times. The market is attributed to changes according to drug development and regulatory imposition, on the basis of the macro and industry-based dynamics.
Request a Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-2843
Prominent development in the market incorporates scaffold-free 3D systems for stem-cell-derived therapies. 3D cell culture is known to create an artificial environment for the growth of cells in order to study their behavior in response to their given environment. 3D cell culture is expected to be defined as the culture of living cells that form a three-dimensional structure and mimic a tissue or an organ. 3D cell culture is excessively used for its convenience and innovative features in comparison to other cell culture methods. 3D cell culture is considered to be scaffold-free or scaffold-based 3D cell culture. Scaffolds are responsible for providing support to the cells. Surging focus on discovering alternatives in order to test animals, expanding focus on customized therapy, growing prevalence of chronic diseases, and increasing availability of research funding are all driving this market forward.
Key Takeaways
- 3D cell culture is known as a suitable alternative in translational and regenerative medicine since it represents a new, advanced, and robust platform for the investigation of complex biological procedures. 3D cell culture is projected to extend to various sectors of scientific research.
- Some improvements have taken place in tissue divergence and cell cohesion segments within the 3D cell culture market. These products are drastically becoming more popular and comprise more applications specifically in the early stages of drug development and other research & innovation.
- Researchers utilize this technology to create physiologically comparable cell cultures that aid in drug development and discovery. The persistent desire to improve efficiency in pharmaceutical R&D is also anticipated to promote the adoption of 3D cell culture products.
- A rising focus on exploring options for animal testing is anticipated to bolster market expansion. This is attributed to several regulatory bodies that have increased efforts to replace, reduce, and refine animals used in tests, as well as to provide rehabilitation for those animals. Non-animal models efficiently convert toxicological and pharmacology data to humans and are also predicted to support demand for alternatives to animal testing.
- Key researchers in the 3D cell culture market are going through tests to advance and create better options for cultivating cells and 3D cell culture provides a vast variety of advantages, including improved information and the ability to perform more effective research.
For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-2843
Key Players:
- 3D Biotek LLC
- Advanced Biomatrix Inc.
- Thermo Fisher Scientific Inc.
- Kuraray Co. Ltd.
- Lonza Group Ltd.
- Corning Incorporated
- Merck & Co. Inc.
- BiomimX SRL
- CN Bio Innovations
- Hurel Corporation
- InSphero AG
- MIMETAS BV
More Insights into the 3D Cell Culture Market
The Chinese market is expected to generate lucrative growth opportunities owing to government support and strategic initiatives. China is expected to put greater emphasis on technology improvements in order to cater to the large patient base.
Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-2843
Key Segments of 3D Cell Culture Industry Survey
3D Cell Culture Market by Product:
- Scaffold-free 3D Cell Culture
- Scaffold-based 3D Cell Culture
3D Cell Culture Market by Application:
- Drug Discovery
- Tissue Regeneration & Regenerative Methods
- Cancer Research
- Stem Cell Technology
- Others
3D Cell Culture Market by End User:
- Biotechnology and Pharmaceutical Industries
- Hospital Laboratories
- Academic Research and Institutes
- Contract Research Organizations
Table of Content
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
2.3. Exclusion and Inclusion
3. 3D Cell Culture Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
Get detailed TOC and Report Preview @ https://www.futuremarketinsights.com/reports/3d-cell-culture-market
Have a Look at Related Research Reports of Healthcare
Therapeutic Nuclear Medicines Market Size : Expanding at a CAGR of 10.6%, the global therapeutic nuclear medicines market is projected to increase from a valuation of US$ 1 Bn in 2022 to US$ 1.84 Bn by 2028.
Radiation-Induced Myelosuppression Treatment Market Share : Sales in the global Radiation-Induced Myelosuppression Treatment Market are slated to total US$ 2.9 Bn in 2022. Expanding at a steady 3.1% CAGR, the market valuation is projected to top US$ 3.5 Bn in 2028.
Brain Monitoring Systems Market Growth : The global brain monitoring systems market is currently worth US$ 4.66 Bn and is anticipated to progress at a CAGR of 5.9% to reach a valuation of US$ 6.56 Bn by the end of 2028.
Chemotherapy-Induced Myelosuppression Treatment Market Technology : The global chemotherapy-induced myelosuppression treatment market stands at a net worth of US$ 8.06 Bn in 2022, and is predicted to rise at a CAGR of 3.3% over the forecast period to attain a valuation of US$ 9.78 Bn by 2028.
Over-the-Counter Pain Medication Market Analysis : Global consumption of over-the-counter pain medication currently accounts for a revenue of US$ 21.8 Bn in 2022, and is estimated to attain a valuation of US$ 27.7 Bn by the end of 2028.
About Future Market Insights, Inc.
Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Source: https://www.prnewswire.com/news-releases/3d-cell-culture-market-is-projected-to-grow-at-9-9-cagr-through-2028--future-market-insights-300792964.html
